Picture of AtriCure logo

ATRC AtriCure Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Momentum

Relative Strength (%)
1m-16.23%
3m-30%
6m-42.63%
1yr-43.13%
Volume Change (%)
10d/3m+33.48%
Price vs... (%)
52w High-52.24%
50d MA-15.57%
200d MA-30.29%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-4.95%
Return on Equity-6.6%
Operating Margin-6.68%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of AtriCure EPS forecast chart

Profile Summary

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
October 31st, 2000
Public Since
August 5th, 2005
No. of Shareholders
67
No. of Employees
1,200
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Market
Shares in Issue
47,587,966

ATRC Share Price Performance

Upcoming Events for ATRC

Q1 2024 AtriCure Inc Earnings Release

AtriCure Inc Annual Shareholders Meeting

AtriCure Inc Annual Shareholders Meeting

Q2 2024 AtriCure Inc Earnings Release

Similar to ATRC

Picture of 908 Devices. logo

908 Devices.

us flag iconNASDAQ Global Market

Picture of Alpha Teknova logo

Alpha Teknova

us flag iconNASDAQ Global Market

Picture of Brainsway logo

Brainsway

us flag iconNASDAQ Global Market

Picture of Castle Biosciences logo

Castle Biosciences

us flag iconNASDAQ Global Market

Picture of Cerus logo

Cerus

us flag iconNASDAQ Global Market

FAQ